Industry: Medical Devices & Consumables
Published Date: 2024-11-12
Pages: 70 Pages
Report ld: 3369036
Request Sample
Customized Report
The global Cardiac Surgery Biopatch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
A cardiac surgery biopatch is a patch of biomaterial used in cardiac surgery to repair or replace damaged heart tissue, such as ventricular walls, valves, or other cardiac structures. These patches can be of natural or synthetic origin and need to have good biocompatibility, mechanical strength and durability.
North American market for Cardiac Surgery Biopatch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cardiac Surgery Biopatch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cardiac Surgery Biopatch include Ethicon, LeMaitre, Beijing Bairen Medical Technology, KingstronBio, Shanghai Cingular Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Cardiac Surgery Biopatch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Surgery Biopatch.
The Cardiac Surgery Biopatch market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cardiac Surgery Biopatch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Surgery Biopatch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ethicon
LeMaitre
Beijing Bairen Medical Technology
KingstronBio
Shanghai Cingular Biotech
Segment by Type
Bio-Mesh of Animal Origin
Allogeneic Patch
Synthetic Material Patch
Segment by Application
Atrial Septal Defect Repair
Ventricular Septal Defect Repair
Valve Repair
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiac Surgery Biopatch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiac Surgery Biopatch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Cardiac Surgery Biopatch Market Overview
1.1 Product Definition
1.2 Cardiac Surgery Biopatch by Type
1.2.1 Global Cardiac Surgery Biopatch Market Value Comparison by Type (2024-2030)
1.2.2 Bio-Mesh of Animal Origin
1.2.3 Allogeneic Patch
1.2.4 Synthetic Material Patch
1.3 Cardiac Surgery Biopatch by Application
1.3.1 Global Cardiac Surgery Biopatch Market Value by Application (2024-2030)
1.3.2 Atrial Septal Defect Repair
1.3.3 Ventricular Septal Defect Repair
1.3.4 Valve Repair
1.3.5 Others
1.4 Global Cardiac Surgery Biopatch Market Size Estimates and Forecasts
1.4.1 Global Cardiac Surgery Biopatch Revenue 2019-2030
1.4.2 Global Cardiac Surgery Biopatch Sales 2019-2030
1.4.3 Global Cardiac Surgery Biopatch Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cardiac Surgery Biopatch Market Competition by Manufacturers
2.1 Global Cardiac Surgery Biopatch Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cardiac Surgery Biopatch Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cardiac Surgery Biopatch Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Cardiac Surgery Biopatch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiac Surgery Biopatch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiac Surgery Biopatch, Product Type & Application
2.7 Global Key Manufacturers of Cardiac Surgery Biopatch, Date of Enter into This Industry
2.8 Global Cardiac Surgery Biopatch Market Competitive Situation and Trends
2.8.1 Global Cardiac Surgery Biopatch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cardiac Surgery Biopatch Players Market Share by Revenue
2.8.3 Global Cardiac Surgery Biopatch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cardiac Surgery Biopatch Market Scenario by Region
3.1 Global Cardiac Surgery Biopatch Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cardiac Surgery Biopatch Sales by Region: 2019-2030
3.2.1 Global Cardiac Surgery Biopatch Sales by Region: 2019-2024
3.2.2 Global Cardiac Surgery Biopatch Sales by Region: 2025-2030
3.3 Global Cardiac Surgery Biopatch Revenue by Region: 2019-2030
3.3.1 Global Cardiac Surgery Biopatch Revenue by Region: 2019-2024
3.3.2 Global Cardiac Surgery Biopatch Revenue by Region: 2025-2030
3.4 North America Cardiac Surgery Biopatch Market Facts & Figures by Country
3.4.1 North America Cardiac Surgery Biopatch Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cardiac Surgery Biopatch Sales by Country (2019-2030)
3.4.3 North America Cardiac Surgery Biopatch Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cardiac Surgery Biopatch Market Facts & Figures by Country
3.5.1 Europe Cardiac Surgery Biopatch Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cardiac Surgery Biopatch Sales by Country (2019-2030)
3.5.3 Europe Cardiac Surgery Biopatch Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiac Surgery Biopatch Market Facts & Figures by Region
3.6.1 Asia Pacific Cardiac Surgery Biopatch Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cardiac Surgery Biopatch Sales by Region (2019-2030)
3.6.3 Asia Pacific Cardiac Surgery Biopatch Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cardiac Surgery Biopatch Market Facts & Figures by Country
3.7.1 Latin America Cardiac Surgery Biopatch Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cardiac Surgery Biopatch Sales by Country (2019-2030)
3.7.3 Latin America Cardiac Surgery Biopatch Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cardiac Surgery Biopatch Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiac Surgery Biopatch Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cardiac Surgery Biopatch Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cardiac Surgery Biopatch Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiac Surgery Biopatch Sales by Type (2019-2030)
4.1.1 Global Cardiac Surgery Biopatch Sales by Type (2019-2024)
4.1.2 Global Cardiac Surgery Biopatch Sales by Type (2025-2030)
4.1.3 Global Cardiac Surgery Biopatch Sales Market Share by Type (2019-2030)
4.2 Global Cardiac Surgery Biopatch Revenue by Type (2019-2030)
4.2.1 Global Cardiac Surgery Biopatch Revenue by Type (2019-2024)
4.2.2 Global Cardiac Surgery Biopatch Revenue by Type (2025-2030)
4.2.3 Global Cardiac Surgery Biopatch Revenue Market Share by Type (2019-2030)
4.3 Global Cardiac Surgery Biopatch Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cardiac Surgery Biopatch Sales by Application (2019-2030)
5.1.1 Global Cardiac Surgery Biopatch Sales by Application (2019-2024)
5.1.2 Global Cardiac Surgery Biopatch Sales by Application (2025-2030)
5.1.3 Global Cardiac Surgery Biopatch Sales Market Share by Application (2019-2030)
5.2 Global Cardiac Surgery Biopatch Revenue by Application (2019-2030)
5.2.1 Global Cardiac Surgery Biopatch Revenue by Application (2019-2024)
5.2.2 Global Cardiac Surgery Biopatch Revenue by Application (2025-2030)
5.2.3 Global Cardiac Surgery Biopatch Revenue Market Share by Application (2019-2030)
5.3 Global Cardiac Surgery Biopatch Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ethicon
6.1.1 Ethicon Company Information
6.1.2 Ethicon Description and Business Overview
6.1.3 Ethicon Cardiac Surgery Biopatch Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ethicon Cardiac Surgery Biopatch Product Portfolio
6.1.5 Ethicon Recent Developments/Updates
6.2 LeMaitre
6.2.1 LeMaitre Company Information
6.2.2 LeMaitre Description and Business Overview
6.2.3 LeMaitre Cardiac Surgery Biopatch Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LeMaitre Cardiac Surgery Biopatch Product Portfolio
6.2.5 LeMaitre Recent Developments/Updates
6.3 Beijing Bairen Medical Technology
6.3.1 Beijing Bairen Medical Technology Company Information
6.3.2 Beijing Bairen Medical Technology Description and Business Overview
6.3.3 Beijing Bairen Medical Technology Cardiac Surgery Biopatch Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Beijing Bairen Medical Technology Cardiac Surgery Biopatch Product Portfolio
6.3.5 Beijing Bairen Medical Technology Recent Developments/Updates
6.4 KingstronBio
6.4.1 KingstronBio Company Information
6.4.2 KingstronBio Description and Business Overview
6.4.3 KingstronBio Cardiac Surgery Biopatch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KingstronBio Cardiac Surgery Biopatch Product Portfolio
6.4.5 KingstronBio Recent Developments/Updates
6.5 Shanghai Cingular Biotech
6.5.1 Shanghai Cingular Biotech Company Information
6.5.2 Shanghai Cingular Biotech Description and Business Overview
6.5.3 Shanghai Cingular Biotech Cardiac Surgery Biopatch Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Cingular Biotech Cardiac Surgery Biopatch Product Portfolio
6.5.5 Shanghai Cingular Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiac Surgery Biopatch Industry Chain Analysis
7.2 Cardiac Surgery Biopatch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiac Surgery Biopatch Production Mode & Process
7.4 Cardiac Surgery Biopatch Sales and Marketing
7.4.1 Cardiac Surgery Biopatch Sales Channels
7.4.2 Cardiac Surgery Biopatch Distributors
7.5 Cardiac Surgery Biopatch Customers
8 Cardiac Surgery Biopatch Market Dynamics
8.1 Cardiac Surgery Biopatch Industry Trends
8.2 Cardiac Surgery Biopatch Market Drivers
8.3 Cardiac Surgery Biopatch Market Challenges
8.4 Cardiac Surgery Biopatch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Cardiac Surgery Biopatch market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 117
USD 4900.00
(Single User License)
The global Cardiac Surgery Biopatch market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 72
USD 4250.00
(Single User License)
The global market for Cardiac Surgery Biopatch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 84
USD 3950.00
(Single User License)
The global Cardiac Surgery Biopatch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 95
USD 2900.00
(Single User License)
The global Cardiac Surgery Biopatch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 116
USD 4900.00
(Single User License)
The global Cardiac Surgery Biopatch market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 66
USD 4250.00
(Single User License)
The global market for Cardiac Surgery Biopatch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 83
USD 3950.00
(Single User License)
The global market for Cardiac Surgery Biopatch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 72
USD 2900.00
(Single User License)
The global Cardiac Surgery Biopatch market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-11-12
Pages: 118
USD 4900.00
(Single User License)
The global Cardiac Surgery Biopatch revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-11-12
Pages: 97
USD 4350.00
(Single User License)
The global Cardiac Surgery Biopatch market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 117
The global Cardiac Surgery Biopatch market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 72
The global market for Cardiac Surgery Biopatch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 84
The global Cardiac Surgery Biopatch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 95
The global Cardiac Surgery Biopatch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 116
The global Cardiac Surgery Biopatch market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 66
The global market for Cardiac Surgery Biopatch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 83
The global market for Cardiac Surgery Biopatch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 72
The global Cardiac Surgery Biopatch market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-11-12
Pages: 118
The global Cardiac Surgery Biopatch revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-11-12
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now